A 52-year-old man with diabetes mellitus type 2 and hypertension presents with progressive fatigue and nocturia for 6 months. Serum creatinine is 2.8 mg/dL, eGFR 24 mL/min/1.73m², and urinalysis shows 2+ proteinuria. Which investigation is most appropriate to confirm the diagnosis and assess the degree of renal fibrosis in chronic kidney disease?

Explanation

## Investigation of Choice for CKD Diagnosis and Fibrosis Assessment ### Clinical Context This patient presents with advanced CKD (Stage 3b–4) with proteinuria, likely secondary to diabetic nephropathy. The question asks for the investigation that **confirms diagnosis AND assesses fibrosis**—this is the domain of renal biopsy. ### Why Renal Biopsy is the Answer **Key Point:** Renal biopsy with light microscopy (LM), immunofluorescence (IF), and electron microscopy (EM) is the **gold standard for definitive diagnosis and histological assessment of fibrosis/scarring** in CKD. **High-Yield:** The three-component biopsy protocol provides: - **Light microscopy:** Glomerular and tubular architecture, degree of glomerulosclerosis, interstitial fibrosis, tubular atrophy (IFTA) - **Immunofluorescence:** Immune complex deposition patterns (IgA, IgG, IgM, C3, C1q) - **Electron microscopy:** Ultrastructural detail (basement membrane thickness, podocyte foot process fusion, electron-dense deposits) ### Fibrosis Grading Histological fibrosis is quantified as a percentage of cortical area involved and is a **strong independent predictor of CKD progression and renal survival**. **Clinical Pearl:** Although this patient likely has diabetic nephropathy (proteinuria + diabetes + hypertension), biopsy is indicated when: - Atypical features present (rapid decline, absence of retinopathy, hematuria) - Need to assess stage and reversibility - Prognostic counselling required ### Comparison with Other Investigations | Investigation | Purpose | Limitation | |---|---|---| | **Renal biopsy (LM+IF+EM)** | Definitive diagnosis + fibrosis staging | Invasive; risk of bleeding, infection | | 24-hour urine protein | Quantifies proteinuria; monitors progression | Does NOT diagnose etiology or assess fibrosis | | Renal artery duplex | Rules out renal artery stenosis | Not indicated unless clinical suspicion for secondary HTN | | CT angiography | Excludes vascular disease | Radiation + contrast; not diagnostic for parenchymal disease | **Warning:** Do not confuse **diagnostic biopsy** (needed here for etiology + fibrosis) with **screening tests** (eGFR, proteinuria) — the latter guide referral but do not stage fibrosis. [cite:Harrison 21e Ch 279]